Andrew Cunningham

Andrew Cunningham

Chief Tech/Sci/R&D Officer at CALCIMEDICA, INC.
Health Technology
Consumer Services

Profile

Andrew Cunningham is Senior Vice President-Clinical Development at CalciMedica, Inc. since 2023.
Formerly, Dr. Cunningham was Head-Neurodegenerative at Taysha Gene Therapies, Inc. from 2021 to 2022, Vice President-Clinical Development at Reata Pharmaceuticals, Inc. from 2018 to 2021, Medical Director at Takeda Pharmaceutical Co., Ltd. from 2017 to 2018, and Medical Director at Genzyme Therapeutics Ltd. from 2012 to 2014.
Dr. Cunningham completed undergraduate and MBA degrees at University College Dublin.

Andrew Cunningham active positions

CompaniesPositionStart
CALCIMEDICA, INC. Chief Tech/Sci/R&D Officer 23/05/2023

Former positions of Andrew Cunningham

CompaniesPositionEnd
TAYSHA GENE THERAPIES, INC. Corporate Officer/Principal 01/04/2022
REATA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/02/2021
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/07/2018
Corporate Officer/Principal 01/06/2014
See the detail of Andrew Cunningham's experience

Training of Andrew Cunningham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

44

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Andrew Cunningham